Literature DB >> 22778009

Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Jennifer G Goldman1, Holly Weis, Glenn Stebbins, Bryan Bernard, Christopher G Goetz.   

Abstract

Mild cognitive impairment is increasingly recognized as a construct in Parkinson's disease (PD) and occurs in about 25% of nondemented PD patients. Although executive dysfunction is the most frequent type of cognitive deficit in PD, the cognitive phenotype of PD mild cognitive impairment (PD-MCI) is broad. PD-MCI subtypes are represented by amnestic and nonamnestic domain impairment as well as single- and multiple-domain impairment. However, it is unclear whether patients with different PD-MCI subtypes also differ in other clinical characteristics in addition to cognitive profile. We studied 128 PD-MCI subjects at our Movement Disorders center, comparing clinical, motor, and behavioral characteristics across the PD-MCI subtypes. We found varying proportions of impairment subtypes: nonamnestic single domain, 47.7%; amnestic multiple domain, 24.2%; amnestic single domain, 18.8%; and nonamnestic multiple domain, 9.5%. Attentional/executive functioning and visuospatial abilities were the most frequently impaired domains. PD-MCI subtypes differed in their motor features, with nonamnestic multiple-domain PD-MCI subjects showing particularly pronounced problems with postural instability and gait. Differences among PD-MCI subtypes in age, PD duration, medication use, mood or behavioral disturbances, and vascular disease were not significant. Thus, in addition to differing cognitive profiles, PD-MCI subtypes differed in motor phenotype and severity but not in mood, behavioral, or vascular comorbidities. Greater postural instability and gait disturbances in the nonamnestic multiple-domain subtype emphasize shared nondopaminergic neural substrates of gait and cognition in PD. Furthermore, increased burden of cognitive dysfunction, rather than type of cognitive deficit, may be associated with greater motor impairment in PD-MCI.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22778009      PMCID: PMC3412930          DOI: 10.1002/mds.25062

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  73 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Assessment of lifetime participation in cognitively stimulating activities.

Authors:  Robert Wilson; Lisa Barnes; David Bennett
Journal:  J Clin Exp Neuropsychol       Date:  2003-08       Impact factor: 2.475

4.  Cognitive impairments in advanced PD without dementia.

Authors:  J Green; W M McDonald; J L Vitek; M Evatt; A Freeman; M Haber; R A E Bakay; S Triche; B Sirockman; M R DeLong
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

5.  Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

Authors:  D Aarsland; J P Larsen; E Tandberg; K Laake
Journal:  J Am Geriatr Soc       Date:  2000-08       Impact factor: 5.562

6.  Effects of cognitive challenge on gait variability in patients with Parkinson's disease.

Authors:  Jeffrey M Hausdorff; Jackov Balash; Nir Giladi
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-03       Impact factor: 2.680

7.  Mortality in Parkinson's disease and its association with dementia and depression.

Authors:  T A Hughes; H F Ross; R H S Mindham; E G S Spokes
Journal:  Acta Neurol Scand       Date:  2004-08       Impact factor: 3.209

8.  Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.

Authors:  Francesca Cormack; Dag Aarsland; Clive Ballard; Martin J Tovée
Journal:  Int J Geriatr Psychiatry       Date:  2004-04       Impact factor: 3.485

9.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

Authors:  Dag Aarsland; Kjeld Andersen; Jan P Larsen; Anette Lolk; Per Kragh-Sørensen
Journal:  Arch Neurol       Date:  2003-03

10.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501

View more
  40 in total

1.  GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Debby Tsuang; Haley Huston; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

Review 2.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

3.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

Review 4.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

5.  Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.

Authors:  Lilah M Besser; Irene Litvan; Sarah E Monsell; Charles Mock; Sandra Weintraub; Xiao-Hua Zhou; Walter Kukull
Journal:  Parkinsonism Relat Disord       Date:  2016-04-09       Impact factor: 4.891

6.  Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease.

Authors:  Rasheda El-Nazer; Charles H Adler; Thomas G Beach; Christine M Belden; Jonathan Artz; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Edward Zamrini; Jared F Benge
Journal:  Parkinsonism Relat Disord       Date:  2019-05-10       Impact factor: 4.891

7.  Mild Cognitive Impairment Subtypes in a Cohort of Elderly Essential Tremor Cases.

Authors:  Kathleen Collins; Brittany Rohl; Sarah Morgan; Edward D Huey; Elan D Louis; Stephanie Cosentino
Journal:  J Int Neuropsychol Soc       Date:  2017-04-03       Impact factor: 2.892

8.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

9.  Measuring mild cognitive impairment in patients with Parkinson's disease.

Authors:  Connie Marras; Melissa J Armstrong; Christopher A Meaney; Susan Fox; Brandon Rothberg; William Reginold; David F Tang-Wai; David Gill; Paul J Eslinger; Cindy Zadikoff; Nancy Kennedy; Fred J Marshall; Mark Mapstone; Kelvin L Chou; Carol Persad; Irene Litvan; Benjamin T Mast; Adam T Gerstenecker; Sandra Weintraub; Sarah Duff-Canning
Journal:  Mov Disord       Date:  2013-03-20       Impact factor: 10.338

10.  APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Howard I Hurtig; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Shannon L Rhodes; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Shu-Ching Hu; Brenna A Cholerton; Jia Y Wan; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.